Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
a shingles vaccine was given in 2019 and one today; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received first dose in 2019). On 17-JUN-2025, the patient received the 2nd dose of Shingles vaccine. On 17-JUN-2025, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too long (Verbatim: a shingles vaccine was given in 2019 and one today). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 17-JUN-2025 The Licensed Practical Nurse contacted and mentioned product, enquired if a Shingles vaccine was given in 2019 and one today which led to lengthening of vaccination schedule. The reporter enquired if they need another one if it was 6 years between. No clarification was obtained in regard to the specific name of the vaccine.